Inflammatory cell infiltration of tumors

Jekyll or Hyde

James E Talmadge, Moses Donkor, Eric Scholar

Research output: Contribution to journalReview article

207 Citations (Scopus)

Abstract

Inflammatory cell infiltration of tumors contributes either positively or negatively to tumor invasion, growth, metastasis, and patient outcomes, creating a Dr. Jekyll or Mr. Hyde conundrum when examining mechanisms of action. This is due to tumor heterogeneity and the diversity of the inflammatory cell phenotypes that infiltrate primary and metastatic lesions. Tumor infiltration by macrophages is generally associated with neoangiogenesis and negative outcomes, whereas dendritic cell (DC) infiltration is typically associated with a positive clinical outcome in association with their ability to present tumor antigens (Ags) and induce Ag-specific T cell responses. Myeloid-derived suppressor cells (MDSCs) also infiltrate tumors, inhibiting immune responses and facilitating tumor growth and metastasis. In contrast, T cell infiltration of tumors provides a positive prognostic surrogate, although subset analyses suggest that not all infiltrating T cells predict a positive outcome. In general, infiltration by CD8+ T cells predicts a positive outcome, while CD4+ cells predict a negative outcome. Therefore, the analysis of cellular phenotypes and potentially spatial distribution of infiltrating cells are critical for an accurate assessment of outcome. Similarly, cellular infiltration of metastatic foci is also a critical parameter for inducing therapeutic responses, as well as establishing tumor dormancy. Current strategies for cellular, gene, and molecular therapies are focused on the manipulation of infiltrating cellular populations. Within this review, we discuss the role of tumor infiltrating, myeloid-monocytic cells, and T lymphocytes, as well as their potential for tumor control, immunosuppression, and facilitation of metastasis.

Original languageEnglish (US)
Pages (from-to)373-400
Number of pages28
JournalCancer and Metastasis Reviews
Volume26
Issue number3-4
DOIs
StatePublished - Dec 1 2007

Fingerprint

Neoplasms
T-Lymphocytes
Neoplasm Metastasis
Phenotype
Neoplasm Antigens
Myeloid Cells
Growth
Genetic Therapy
Immunosuppression
Dendritic Cells
Macrophages
Outcome Assessment (Health Care)
Population
Therapeutics

Keywords

  • Dendritic cell
  • Macrophage
  • Myeloid-derived suppressor cell
  • Prognostic surrogate
  • T lymphocyte
  • Tumor infiltration

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inflammatory cell infiltration of tumors : Jekyll or Hyde. / Talmadge, James E; Donkor, Moses; Scholar, Eric.

In: Cancer and Metastasis Reviews, Vol. 26, No. 3-4, 01.12.2007, p. 373-400.

Research output: Contribution to journalReview article

Talmadge, James E ; Donkor, Moses ; Scholar, Eric. / Inflammatory cell infiltration of tumors : Jekyll or Hyde. In: Cancer and Metastasis Reviews. 2007 ; Vol. 26, No. 3-4. pp. 373-400.
@article{3750548113b74e95af8c41f9f473f9fe,
title = "Inflammatory cell infiltration of tumors: Jekyll or Hyde",
abstract = "Inflammatory cell infiltration of tumors contributes either positively or negatively to tumor invasion, growth, metastasis, and patient outcomes, creating a Dr. Jekyll or Mr. Hyde conundrum when examining mechanisms of action. This is due to tumor heterogeneity and the diversity of the inflammatory cell phenotypes that infiltrate primary and metastatic lesions. Tumor infiltration by macrophages is generally associated with neoangiogenesis and negative outcomes, whereas dendritic cell (DC) infiltration is typically associated with a positive clinical outcome in association with their ability to present tumor antigens (Ags) and induce Ag-specific T cell responses. Myeloid-derived suppressor cells (MDSCs) also infiltrate tumors, inhibiting immune responses and facilitating tumor growth and metastasis. In contrast, T cell infiltration of tumors provides a positive prognostic surrogate, although subset analyses suggest that not all infiltrating T cells predict a positive outcome. In general, infiltration by CD8+ T cells predicts a positive outcome, while CD4+ cells predict a negative outcome. Therefore, the analysis of cellular phenotypes and potentially spatial distribution of infiltrating cells are critical for an accurate assessment of outcome. Similarly, cellular infiltration of metastatic foci is also a critical parameter for inducing therapeutic responses, as well as establishing tumor dormancy. Current strategies for cellular, gene, and molecular therapies are focused on the manipulation of infiltrating cellular populations. Within this review, we discuss the role of tumor infiltrating, myeloid-monocytic cells, and T lymphocytes, as well as their potential for tumor control, immunosuppression, and facilitation of metastasis.",
keywords = "Dendritic cell, Macrophage, Myeloid-derived suppressor cell, Prognostic surrogate, T lymphocyte, Tumor infiltration",
author = "Talmadge, {James E} and Moses Donkor and Eric Scholar",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/s10555-007-9072-0",
language = "English (US)",
volume = "26",
pages = "373--400",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "3-4",

}

TY - JOUR

T1 - Inflammatory cell infiltration of tumors

T2 - Jekyll or Hyde

AU - Talmadge, James E

AU - Donkor, Moses

AU - Scholar, Eric

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Inflammatory cell infiltration of tumors contributes either positively or negatively to tumor invasion, growth, metastasis, and patient outcomes, creating a Dr. Jekyll or Mr. Hyde conundrum when examining mechanisms of action. This is due to tumor heterogeneity and the diversity of the inflammatory cell phenotypes that infiltrate primary and metastatic lesions. Tumor infiltration by macrophages is generally associated with neoangiogenesis and negative outcomes, whereas dendritic cell (DC) infiltration is typically associated with a positive clinical outcome in association with their ability to present tumor antigens (Ags) and induce Ag-specific T cell responses. Myeloid-derived suppressor cells (MDSCs) also infiltrate tumors, inhibiting immune responses and facilitating tumor growth and metastasis. In contrast, T cell infiltration of tumors provides a positive prognostic surrogate, although subset analyses suggest that not all infiltrating T cells predict a positive outcome. In general, infiltration by CD8+ T cells predicts a positive outcome, while CD4+ cells predict a negative outcome. Therefore, the analysis of cellular phenotypes and potentially spatial distribution of infiltrating cells are critical for an accurate assessment of outcome. Similarly, cellular infiltration of metastatic foci is also a critical parameter for inducing therapeutic responses, as well as establishing tumor dormancy. Current strategies for cellular, gene, and molecular therapies are focused on the manipulation of infiltrating cellular populations. Within this review, we discuss the role of tumor infiltrating, myeloid-monocytic cells, and T lymphocytes, as well as their potential for tumor control, immunosuppression, and facilitation of metastasis.

AB - Inflammatory cell infiltration of tumors contributes either positively or negatively to tumor invasion, growth, metastasis, and patient outcomes, creating a Dr. Jekyll or Mr. Hyde conundrum when examining mechanisms of action. This is due to tumor heterogeneity and the diversity of the inflammatory cell phenotypes that infiltrate primary and metastatic lesions. Tumor infiltration by macrophages is generally associated with neoangiogenesis and negative outcomes, whereas dendritic cell (DC) infiltration is typically associated with a positive clinical outcome in association with their ability to present tumor antigens (Ags) and induce Ag-specific T cell responses. Myeloid-derived suppressor cells (MDSCs) also infiltrate tumors, inhibiting immune responses and facilitating tumor growth and metastasis. In contrast, T cell infiltration of tumors provides a positive prognostic surrogate, although subset analyses suggest that not all infiltrating T cells predict a positive outcome. In general, infiltration by CD8+ T cells predicts a positive outcome, while CD4+ cells predict a negative outcome. Therefore, the analysis of cellular phenotypes and potentially spatial distribution of infiltrating cells are critical for an accurate assessment of outcome. Similarly, cellular infiltration of metastatic foci is also a critical parameter for inducing therapeutic responses, as well as establishing tumor dormancy. Current strategies for cellular, gene, and molecular therapies are focused on the manipulation of infiltrating cellular populations. Within this review, we discuss the role of tumor infiltrating, myeloid-monocytic cells, and T lymphocytes, as well as their potential for tumor control, immunosuppression, and facilitation of metastasis.

KW - Dendritic cell

KW - Macrophage

KW - Myeloid-derived suppressor cell

KW - Prognostic surrogate

KW - T lymphocyte

KW - Tumor infiltration

UR - http://www.scopus.com/inward/record.url?scp=36148960830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148960830&partnerID=8YFLogxK

U2 - 10.1007/s10555-007-9072-0

DO - 10.1007/s10555-007-9072-0

M3 - Review article

VL - 26

SP - 373

EP - 400

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 3-4

ER -